With regard to the choice of bone-protecting agent, denosumab (Xgeva) improved bone density and reduced fracture risk in a placebo-controlled trial involving men with non-metastatic HSPC. Denosumab ...

Some of the most important players on NFL teams are those that might not necessarily start the season on the field. Depth is ...

Expert behind new Shark Week doc separates truth from fiction in the movie series and explains why Jaws 2 is more realistic ...